13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0000904454-25-000124
Total Value
$386.1M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $94.5M | 24.48% |
| 2 | CVRx, Inc. | CVRX | 4,103,430 | $52.0M | 13.46% |
| 3 | Rapport Therapeutics, Inc. | RAPP | 2,498,051 | $44.3M | 11.48% |
| 4 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $40.4M | 10.47% |
| 5 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $29.0M | 7.51% |
| 6 | Procept BioRobotics Corporation | PRCT | 357,939 | $28.8M | 7.46% |
| 7 | Legend Biotech Corporation | LEGN | 814,586 | $26.5M | 6.86% |
| 8 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $19.6M | 5.08% |
| 9 | Xencor, Inc. | XNCR | 748,062 | $17.2M | 4.45% |
| 10 | Nanobiotix S.A. | NBTX | 5,623,816 | $16.1M | 4.18% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $5.6M | 1.44% |
| 12 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $4.7M | 1.21% |
| 13 | Rallybio Corporation | RLYB | 3,636,363 | $3.5M | 0.90% |
| 14 | Vor Biopharma, Inc. | VOR | 1,074,658 | $1.2M | 0.31% |
| 15 | Nano-X Imaging Ltd. | NNOX | 158,852 | $1.1M | 0.30% |
| 16 | Standard BioTools Inc | LAB | 311,967 | $545,942 | 0.14% |
| 17 | Lyell Immunopharma Inc. | LYEL | 823,317 | $526,923 | 0.14% |
| 18 | Adicet Bio, Inc. | ACET | 364,472 | $350,622 | 0.09% |
| 19 | BiomX Inc. | PHGE | 96,866 | $70,722 | 0.02% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $28,589 | 0.01% |